Registry following adults with migraine after middle meningeal artery embolization
Records outcomes in adults with migraine who had or plan artery embolization.
Key facts
- Who runs it
- Cortex Neurovascular
- Where
- Tacoma, United StatesSee the site
- Trial code
- Registry title
- EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 1 Jun 2028
- Type of study
- Observational
- Treatments tested
- Middle Meningeal Artery Embolization
- Record updated
- 23 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 64 with migraine who have had, or plan to have, a procedure called middle meningeal artery (MMA) embolization as part of routine care.
- Age
- 18 to 64 years
- Sex
- All sexes can join.
- Disease stage
- A diagnosis of migraine.
- Earlier treatment
- Has had, or plans to have, middle meningeal artery (MMA) embolization as part of routine clinical care.
Main reasons for not taking part
- Under 18 years old
- Pregnant at the time of enrollment
- Cannot give informed consent
- Cannot read and understand English well enough for the consent and questionnaires
- Not enough clinical or patient-reported outcome data for the planned analyses
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adults aged 18 to 64 years
- Diagnosis of migraine
- Have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care, independent of study participation
- Able and willing to provide informed consent
- Able to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments
Who cannot take part
- Age under 18 years
- Pregnancy at the time of enrollment
- Inability to provide informed consent
- Inability to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments
- Insufficient clinical or patient-reported outcome data for the planned analyses
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in United States
- Cortex Neurovascular / TRA UnionTacoma, United StatesContact: Dennis Wang, MDTaking people
About the trial
What the trial wants to find out
EMBRACE-OBS is the first phase of the EMBRACE research program. This single-site observational registry accesses and analyzes patient-reported outcome data already collected through routine clinical care from adults with migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization. The study describes changes in headache frequency, headache severity, medication use, migraine-related disability, quality of life, and reported adverse events over time without influencing clinical care.
The group in the trial
- Migraine Patients Undergoing MMA Embolization
Adults aged 18 to 64 years with a diagnosis of migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care. Participants are enrolled in an observational registry that accesses and analyzes clinical and patient-reported outcome data already documented through routine care. Study participation does not influence clinical management, procedural technique, device selection, or follow-up.
Treatment: Middle Meningeal Artery Embolization
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Enduring Migraine Benefit From Responsive Artery Coil Embolization - Observational (EMBRACE-OBS): A Single-Site Registry of Patient-Reported Outcomes Following Routine Clinical Care for Migraine
- Plain-language title
- Registry following adults with migraine after middle meningeal artery embolizationGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07652034, who can take part
- Record updated
- 23 September 2026